DDInter1118 DDInter1676
Magnesium hydroxide is an inorganic compound. It is naturally found as the mineral brucite. Magnesium hydroxide can be used as an antacid or a laxative in either an oral liquid suspension or chewable tablet form. Additionally, magnesium hydroxide has smoke suppressing and flame retardant properties and is thus used commercially as a fire retardant. It can also be used topically as a deodorant or for the relief of canker sores (aphthous ulcers).
Siponimod, also known as _Mayzent_, by Novartis, is a new drug formulated for the management of Multiple Sclerosis (MS). It was approved by the FDA on March 26, 2019 and by Health Canada on February 20, 2020. This drug is considered a _sphingosine-1-phosphate (S1P) receptor modulator_ and is thought to play a role in suppressing the central nervous system inflammation that is associated with MS [FDA label]. Multiple Sclerosis (MS) is an autoimmune disease of the central nervous system that is chronic and inflammatory, disrupting communication between the brain and other parts of the body. Most patients diagnosed with this illness experience their initial disease symptoms between the age of 20 to 40, often the most productive years of life. Symptoms may include but are not limited to fatigue, gait changes, bowel or bladder dysfunction, abnormal muscle twitching, vision disturbance, and depressing or mood swings. MS is one of the most common causes of neurological disability in young adults and is found to occur more frequently in women than in men.[A176474,L5792]
Magnesium hydroxide {u} may cause a minor interaction that can limit clinical effects when taken with {v} Quazepam
Magnesium hydroxide {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Diclofenamide
Magnesium hydroxide {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Deutetrabenazine
Magnesium hydroxide {u} may lead to a major life threatening interaction when taken with {v} Erdafitinib
Magnesium hydroxide {u} may lead to a major life threatening interaction when taken with {v} Tolevamer
Magnesium hydroxide may cause a minor interaction that can limit clinical effects when taken with Quazepam
Magnesium hydroxide may cause a moderate interaction that could exacerbate diseases when taken with Diclofenamide
Magnesium hydroxide may cause a moderate interaction that could exacerbate diseases when taken with Deutetrabenazine
Magnesium hydroxide may lead to a major life threatening interaction when taken with Erdafitinib
Magnesium hydroxide may lead to a major life threatening interaction when taken with Tolevamer